Vitiligo and Pregnancy: Fertility, What Changes, and Which Treatments Are Safe
Vitiligo does not affect fertility. Getting pregnant with vitiligo is safe — there is no evidence that vitiligo causes miscarriage, birth defects, or any pregnancy complication. If this is the question you came here with, that is the direct answer.
What vitiligo does do during pregnancy is behave unpredictably. Your skin may improve, worsen, or stay exactly the same. The mechanisms behind each outcome are reasonably well understood, and knowing what to expect is more useful than worrying about outcomes that are not actually at risk.
What actually changes during pregnancy
Roughly half of patients see no meaningful change to their vitiligo during pregnancy. Of the other half, slightly more tend to see some improvement than worsening — though both outcomes are common enough that neither should come as a surprise.
Why some patients improve: Oestrogen levels rise substantially during pregnancy. Elevated oestrogen can modestly dampen certain aspects of autoimmune activity. In vitiligo, which involves an autoimmune attack on melanocytes, this immune quieting can slow or temporarily reduce the attack. The result, for some patients, is that patches stabilise or lighten less dramatically. This is not a cure and it does not persist after delivery, but it is a real clinical observation.
Why some patients worsen: The immune system goes through a recalibration in the third trimester, becoming more active again as the body prepares for delivery. For some patients this triggers flares — new patches or expansion of existing ones. The timing is not random; the third trimester and the postpartum period are the two higher-risk windows.
These are clinical patterns, not guarantees. Your individual response depends on how active your vitiligo was before conception, your overall immune picture, and factors that are genuinely hard to predict.
The postpartum period
The highest-risk window for vitiligo flares is not actually during pregnancy — it is the three to six months after delivery. When the immune system “rebounds” following childbirth, the relative suppression of pregnancy lifts abruptly. This can trigger new patches or extend existing ones in patients who had been stable throughout.
Knowing this in advance is useful. If you notice spreading in the months after your baby is born, it is not unusual and it is not caused by anything you did wrong. It is the same mechanism that causes other autoimmune conditions — particularly thyroid disease — to flare postpartum. Thyroid autoimmunity and vitiligo co-occur often enough that a postpartum thyroid check is worth requesting from your GP or midwife, especially if you notice fatigue, mood changes, or hair loss alongside your skin.
Effect on the baby
None. Vitiligo cannot be transmitted through the placenta. Your baby will not be born with depigmented patches because you have vitiligo.
There is a hereditary component to vitiligo — if a parent has it, a child has a modestly elevated lifetime risk of developing it themselves. But that risk is about genetics, not about exposure during pregnancy. Having vitiligo while pregnant does not change whether your child will develop it, and the elevated risk is modest, not certain.
Treatments during pregnancy: what is safe and what to avoid
This is where the practical decisions sit. The general principle is to use the least systemic option that gives reasonable control, and to stop anything with inadequate pregnancy safety data.
Generally considered safe:
- Topical tacrolimus (Protopic 0.03%) — systemic absorption from topical application is very low. No documented foetal harm exists in the available data. Most dermatologists continue it for patients with patches on small areas of the body. It is a reasonable option for maintaining treatment during pregnancy, particularly on the face.
- Narrowband UVB phototherapy — no UV light reaches the foetus. Narrowband UVB is used for psoriasis in pregnancy with no documented adverse outcomes, and the same reasoning applies to vitiligo. It is the preferred active treatment option if vitiligo is spreading and you want to do something beyond skincare.
- Mineral sunscreen (SPF 50+) — essential, and safe. Depigmented patches have no melanin and burn quickly. EltaMD UV Clear SPF 46 and Blue Lizard Sensitive SPF 50 are both mineral formulas that are considered safe in pregnancy.
Avoid during pregnancy:
- Ruxolitinib cream (Opzelura) — not recommended. JAK inhibitors have not been adequately studied in human pregnancy, and animal data shows potential risk. Pause ruxolitinib if you are pregnant or actively trying to conceive. Discuss timing with your dermatologist before stopping, particularly if your vitiligo has been responding.
- Oral JAK inhibitors (tofacitinib, upadacitinib) — systemic JAK inhibition is contraindicated in pregnancy. If you are on an oral JAK inhibitor and planning to conceive, the conversation with your dermatologist needs to happen before you start trying.
- High-potency topical corticosteroids over large areas — avoid potent steroids on large body surface areas for extended periods during pregnancy. Low-potency steroids on small areas, short-term, are generally considered acceptable but should still be discussed with your dermatologist.
- High-dose vitamin C supplements — supplemental vitamin C can inhibit tyrosinase, which is relevant to repigmentation. It is not something to take regardless of pregnancy; definitely avoid during pregnancy.
Practical skincare during pregnancy
Treatment decisions aside, there are a few skincare habits that matter throughout pregnancy and especially after delivery.
Mineral sunscreen is the primary intervention. Depigmented skin has no UV protection — it burns faster than surrounding skin, and unprotected sun exposure on surrounding skin deepens tanning, which increases the visible contrast between patches and normal skin. Both effects make vitiligo look worse. Daily SPF 50+ on exposed areas is not optional.
Fragrance-free moisturiser helps prevent the Koebner response — the phenomenon where skin trauma triggers new vitiligo patches at the site of injury. Dry, cracked skin is a form of low-grade trauma. CeraVe Moisturizing Cream is a reasonable choice. Avoid tight waistbands, scratching, and anything that causes repeated friction on normal skin adjacent to patches.
For the full sunscreen protocol and product guidance, see the vitiligo sun protection guide.
FAQ
Does vitiligo affect fertility?
No. Vitiligo is an autoimmune skin condition. It does not involve reproductive organs or hormones in a way that affects the ability to conceive. Women with vitiligo have normal fertility.
Will my baby be born with vitiligo?
No. Vitiligo cannot be transmitted through the placenta. A child of a parent with vitiligo has a modestly elevated lifetime risk of developing it, but that risk is genetic, not caused by having vitiligo during pregnancy. Birth with depigmented patches is not an outcome of gestational exposure.
Can I use Opzelura (ruxolitinib cream) while pregnant?
No. Ruxolitinib cream should be paused during pregnancy. JAK inhibitors have not been studied adequately in human pregnancy and animal studies show potential risk. If you are planning to conceive, discuss the timing with your dermatologist before stopping — your vitiligo may need a transition plan.
Is phototherapy safe during pregnancy?
Yes. Narrowband UVB is generally considered safe during pregnancy and is the preferred active treatment option for vitiligo that is spreading while you are expecting. No UV light reaches the foetus. It has been used for psoriasis in pregnancy without documented adverse effects.
